Literature DB >> 24681532

Awareness of colonoscopy as a screening method for colorectal cancer and its uptake in Spain.

Isa Ricardo-Rodrigues1, Valentin Hernandez-Barrera, Rodrigo Jiménez-García.   

Abstract

The objective of this study was to describe awareness levels of colonoscopy as a screening procedure for colorectal cancer (CRC), to study its uptake and analyze possible associated factors in Spain. This was a cross-sectional study using data from the Oncobarómetro survey, carried out by face-to-face interviews with a representative national sample of the Spanish population aged 18 years and older. Awareness was assessed using the following questions: 'Do you know of any examination procedures or medical technique used to detect cancer?' and 'I'm going to list some screening procedures (including colonoscopy) to see if you know of them as a cancer screening test or whether this is the first time you have heard of them'. To evaluate colonoscopy uptake, participants were asked whether they had undergone a colonoscopy in the past 2 years. The independent variables included sociodemographic, socioeconomic, and health-related factors. 65.7% of the study population was aware of colonoscopy as a screening tool. Individuals from lower socioeconomic groups or those who only had primary education showed a lower level of awareness. 12.8% of participants had undergone a colonoscopy in the past 2 years. This number increased to 45% in the Spanish Autonomous Communities, where screening programs are in place. Colonoscopy screening rates are 10.28 times higher among those who had fecal occult blood testing during the previous 2 years. There is an inverse relationship between social inequality and both awareness and uptake of colonoscopy. Consequently, for screening to be more effective, interventions that reduce barriers to access for target populations should be implemented.

Entities:  

Mesh:

Year:  2014        PMID: 24681532     DOI: 10.1097/CEJ.0000000000000026

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  2 in total

1.  Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages.

Authors:  Jean-François Beaulieu; Elizabeth Herring; Shigeru Kanaoka; Éric Tremblay
Journal:  Oncotarget       Date:  2016-03-22

2.  Is Awareness Enough to Bring Patients to Colorectal Screening?

Authors:  Márton István Dénes; Valentin Nădășan; Călin Molnar; Șerban Bancu; Cristian Oliviu Borz; Zoltán Ábrám
Journal:  Open Med (Wars)       Date:  2018-11-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.